1-20 of 20
Mathieu Meunier
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Measurable Residual Disease (MRD) Determinants, Kinetics and Its Impact on Survival in Patients Treated with Azacitidine and Venetoclax for Acute Myeloid Leukemia in Frontline Setting : A Multicentric Study from French Auraml Group

Mael Heiblig, Gaspar Aspas Requena, Urbain Tauveron-Jalenques, Emmanuelle Tavernier, Jérome Cornillon, Martin Carre, Mathieu Meunier, Ugo Thévenet, Boullanger Fow Heng Nadine, Clémence Santana, Clément Rocher, Sylvain Lamure, Amine Belhabri, Mauricette Michallet, Adrien Contejean, Natacha Mauz, Gian Matteo Pica, Arthur Dony, Zofia Gross
Journal: Blood
Blood (2024) 144 (Supplement 1): 846.
https://doi.org/10.1182/blood-2024-207764
Published: 2024
Journal Articles

Bosutinib for Patients with Previously Treated Chronic Myeloid Leukemia: Results from the French Observational Boseval Study

Philippe Rousselot, Jean-Christophe Ianotto, Philippe Quittet, Maya Hacini, Gabrielle Roth-Guepin, Mathieu Meunier, Frederic Maloisel, Valérie Coiteux, Gabriel Etienne
Journal: Blood
Blood (2024) 144 (Supplement 1): 3150.
https://doi.org/10.1182/blood-2024-200145
Published: 2024
Journal Articles

18-Months Follow-up of the Trial of Imatinib after Ponatinib Induction (TIPI) in the Front-Line Treatment of Chronic Phase (CP) Chronic Myeloid Leukemia (CML) Setting

Franck E. Nicolini, Aude Charbonnier, Martine Escoffre-Barbe, Eric Jourdan, Gabrielle Roth-Guepin, Marc G. Berger, Shanti Ame, Marion Simonet, Hyacinthe A Johnson-Ansah, Viviane Dubruille, Amandine Charbonnier, Philippe Rousselot, Corentin Orvain, Bertrand Joly, Jean-Christophe Ianotto, Emilie Cayssials, Mathieu Meunier, Anne Parry, Valerie Coiteux, Laurence Legros, Hacene Zerazhi, Gabriel Etienne, Philippe Quittet, Ollivier Legrand, Amelie Penot, Lydia Roy, Charlotte Doublet, Stéphane Morisset, Romaine Mayet, Gwenaëlle Garin, Stéphanie Dulucq, Françoise Huguet
Journal: Blood
Blood (2024) 144 (Supplement 1): 478.
https://doi.org/10.1182/blood-2024-198903
Published: 2024
Journal Articles

Preliminary Safety and Biomarker Results of the NLRP3 Inflammasome Inhibitor DFV890 in Adult Patients with Myeloid Diseases: A Phase 1b Study

Guillermo Garcia-Manero, Yasmin Abaza, Peter L. Greenberg, Tamanna Haque, Kyra Velázquez Kennedy, Matteo Giovanni Della Porta, Melissa G Ooi, Maximilian Stahl, Zhuoer Xie, Abhishek A. Mangaonkar, Pinkal Desai, Amy E. DeZern, Alice Garnier, Mathieu Meunier, Anna Maria Pelizzari, Uwe Platzbecker, Katja Sockel, Ashwin Kishtagari, Hongbo Lu, Luca Manganelli, Lexiang Ji, Zheng Yan, Yutong Li, Mike Roy, Ewa Gatlik, Arti Singh, Valerie Beaulieu, Marc Pelletier, Philipp Rauch, Harinder Gill
Journal: Blood
Blood (2024) 144 (Supplement 1): 353.
https://doi.org/10.1182/blood-2024-198326
Published: 2024
Journal Articles

Combining ESA and Luspatercept in Non-RS MDS Patients Having Failed ESA - Results of the Phase 1-2 Part a of the GFM Combola Study

Lionel Ades, Thomas Cluzeau, Thibault Comont, Lorea Aguinaga, Aspasia Stamatoullas, Mathieu Meunier, Emmanuel Gyan, Alice Garnier, Maud D'Aveni, Sylvain Thépot, Marie Sebert, Marius Moldovan, Anouk Walter Petrich, Karine Lemarie, Fatiha Chermat, Michaela Fontenay, Sylvie Chevret, Pierre Fenaux
Journal: Blood
Blood (2024) 144 (Supplement 1): 351.
https://doi.org/10.1182/blood-2024-204791
Published: 2024
Journal Articles

Early Versus Late Onset of ESA in Lower Risk Anemic MDS Patients: Results of the GFM Randomized Phase III EPO-Pretar Trial

Sophie Park, Bohrane Slama, Marius Moldovan, David Rombaut, Marie Templé, Aspasia Stamatoullas, Maud D'Aveni, Stephane Cheze, Sylvain Thepot, Jose Miguel Torregrosa Diaz, Sophie Dimicoli, Mathieu Meunier, Kamel Laribi, Reza Tabrizi, Anne Banos, Alice Garnier, Celia Salanoubat, Adrien Contejean, Mael Heiblig, Laurent Pascal, Clemence Santana, Ali Arar, Ramdane Tekrane, Fatiha Chermat, Olivier Kosmider, Michaela Fontenay, Pierre Fenaux
Journal: Blood
Blood (2024) 144 (Supplement 1): 349.
https://doi.org/10.1182/blood-2024-194510
Published: 2024
Journal Articles

A Phase 2 Prospective Study Evaluating Low-Dose Deferasirox in Patients with Low-Risk Myelodysplastic Syndrome Resistant or Relapsing after Erythropoietin Stimulating Agents (LODEFI)

Mathieu Meunier, Sylvain Thepot, Stanislas Nimubona, Mélanie Véloso, Thibaud Lefebvre, Karim Zoubida, Martine Ropert-Bouchet, Frederic Garban, Shanti Ame, Abdesssamia Gandoul, Claire Reynes, Celia Salanoubat, Sébastien Maury, Kamel Laribi, Pirayeh Eftekhari, Jacques Delaunay, Geoffroy Venton, Clemence Santana, Stephane Cheze, Sophie Dimicoli-Salazar, Mathieu Molimard, Valérie Rolland-Neyret, Sandra David-Tchouda, Sophie Park
Journal: Blood
Blood (2024) 144 (Supplement 1): 1826.
https://doi.org/10.1182/blood-2024-198104
Published: 2024
Journal Articles

Azacytidine and Venetoclax As a Salvage Therapy in Measurable Residual Disease (MRD) Relapse Post Intensive Chemotherapy or Allogenic Stem Cell Transplantation in Acute Myeloid Leukemia Patients : A Multicentric Study from French Auraml Group

Martin Carre, Mathieu Meunier, Zofia Gross, Gaspar Aspas Requena, Urbain Tauveron-Jalenques, Emmanuelle Tavernier, Jérome Cornillon, Ugo Thévenet, Boullanger Fow Heng Nadine, Clémence Santana, Clément Rocher, Sylvain Lamure, Amine Belhabri, Mauricette Michallet, Adrien Contejean, Natacha Mauz, Gian Matteo Pica, Arthur Dony, Mael Heiblig
Journal: Blood
Blood (2024) 144 (Supplement 1): 4335.
https://doi.org/10.1182/blood-2024-208817
Published: 2024
Journal Articles

Azacitidine and Venetoclax As a Salvage Therapy for Relapse after Allogeneic Transplantation for Acute Myeloid Leukemia : A Multicentric Study from French Auraml Group

Emmanuelle Tavernier, Jérôme Cornillon, Zofia Gross, Gaspar Aspas Requena, Urbain Tauveron-Jalenques, Martin Carré, Mathieu Meunier, Ugo Thévenet, Boullanger Fow Heng Nadine, Clémence Santana, Clément Rocher, Sylvain Lamure, Amine Belhabri, Mauricette Michallet, Adrien Contejean, Natacha Mauz, Gian Matteo Pica, Arthur Dony, Mael Heiblig
Journal: Blood
Blood (2024) 144 (Supplement 1): 1518.
https://doi.org/10.1182/blood-2024-203496
Published: 2024
Journal Articles

Impact of Mutational Burden and IPSS-M on Response to ESAs in Lower Risk Myelodysplastic Neoplasms

Marco Gabriele Raddi, Angela Consagra, Luca Rigodanza, Cristina Amato, Alessandro Sanna, Giorgio Mattiuz, Sven De Pourcq, Elena Tofacchi, Maria Diez-Campelo, Juan Carlos Caballero Berrocal, Sophie Park, Mathieu Meunier, Celia Orlando, Michaela Fontenay, Olivier Kosmider, Nicolas Chapuis, Uwe Platzbecker, Katharina Zoldan, Anne Sophie Kubasch, Valeria Santini
Journal: Blood
Blood (2023) 142 (Supplement 1): 4595.
https://doi.org/10.1182/blood-2023-189053
Published: 2023
Journal Articles

Mutational Profile and Dynamics of PPM1D -Mutant Clones in the Spectrum of Myeloid Disorders

Jean Pegliasco, David Fandrei, Florence Pasquier, Nathalie Ibrahim, Maria Kfoury, Guillemette Imbert-De-Tremiolles, Nourhan Lizziek, Céline Berthon, Mael Heiblig, Delphine Lebon, Ambroise Marcais, Mathieu Meunier, Ahmad Aljijakli, Emilie Lemasle, Sylvain Chantepie, Cécile Pautas, Pierre-Yves Dumas, Stephanie Haiat, Cyril Quivoron, Ileana antony-Debre, Sophie Cotteret, Raphael Itzykson, Hervé Dombret, Nicolas Duployez, Nathalie Droin, Christophe Marzac, Elsa Bernard, Jean-Baptiste Micol
Journal: Blood
Blood (2023) 142 (Supplement 1): 4064.
https://doi.org/10.1182/blood-2023-189428
Published: 2023
Journal Articles

CPX-351 in Patients with Newly Diagnosed Post Myeloproliferative Neoplasms Acute Myeloid Leukemia

Sylvain Garciaz, Amine Belhabri, Romain Guieze, Laure Goursaud, Pierre Peterlin, Marie-Pierre Ledoux, Hunault-Berger Mathilde, Safia Chebrek, Jean-Baptiste Robin, Arnaud Pigneux, Sarah Bonnet, Caroline Bonmati, Sarah Bertoli, Thorsten Braun, Sylvain Chantepie, Mathieu Meunier, Mael Heiblig, Thomas Cluzeau, Eric Jourdan, Alban Villate, Christian Recher, Norbert Vey, Jerome Rey
Journal: Blood
Blood (2023) 142 (Supplement 1): 2917.
https://doi.org/10.1182/blood-2023-184591
Published: 2023
Journal Articles

T rial of Imatinib after Ponatinib Induction (TIPI) in the Front-Line Treatment of Chronic Phase (CP) Chronic Myeloid Leukemia (CML) Setting. Report of the First Therapeutic Sequence

Franck E. Nicolini, Aude Charbonnier, Martine Escoffre-Barbe, Eric Jourdan, Gabrielle Roth-Guepin, Marc G. Berger, Shanti Amé, Marion Simonet, Hyacinthe A. Johnson-Ansah, Viviane Dubruille, Amandine Charbonnier, Philippe Rousselot, Corentin Orvain, Bertrand Joly, Jean-Christophe Ianotto, Emilie Cayssials, Mathieu Meunier, Anne Parry, Valerie Coiteux, Laurence Legros, Hacene Zerazhi, Gabriel Etienne, Philippe Quittet, Ollivier Legrand, Amelie Penot, Lydia Roy, Ludovic Fouillet, Stéphane Morisset, Isabelle Tigaud, Romaine Mayet, Gwenaëlle Garin, Jérôme Guitton, Stéphanie Dulucq, Françoise Huguet
Journal: Blood
Blood (2023) 142 (Supplement 1): 445.
https://doi.org/10.1182/blood-2023-181571
Published: 2023
Journal Articles

Real World Use of Azacitidine and Venetoclax in Acute Myeloid Leukemia in Frontline and Relapse/Refractory Settings: A Multicentric Study from French Auraml Group

Zofia Gross, Urbain Tauveron-Jalenques, Gaspar Aspas Requena, Martin Carre, Mathieu Meunier, Emmanuelle Tavernier, Jérôme Cornillon, Amine Belhabri, Mauricette Michallet, Adrien Contejean, Natacha Mauz, Boullanger FOW HENG Nadine, Daciana Claudia Antal, Gian Matteo Pica, Dony Arthur, Clémence Santana, Clement Rocher, Mael Heiblig
Journal: Blood
Blood (2023) 142 (Supplement 1): 590.
https://doi.org/10.1182/blood-2023-187331
Published: 2023
Journal Articles

Impact of the COVID-19 Epidemic on Patients with Myeloproliferative Neoplasia: The French Prospective Observational Study Covim

Laurence Legros, Françoise Boyer perrard, Dana Ranta, Lydia Roy, Mario Ojeda-Uribe, Stephane Giraudier, Nathalie Parquet, Jean Christophe Ianotto, Mathieu Wemeau, Isabelle Plantier, Franck E. Nicolini, Eric Lippert, Pascale Cony-Makhoul, Fiorenza Barraco, Laure Stalnikiewicz, Frederic Garban, Brigitte Dupriez, Francois Girodon, Anne Brignier, Yazid Arkam, Mathieu Meunier, Chloe James, Valérie Rolland-Neyret, Valerie Ugo, Pierre Morel, Marie C Bene, Jean-Jacques Kiladjian
Journal: Blood
Blood (2022) 140 (Supplement 1): 6847–6849.
https://doi.org/10.1182/blood-2022-156632
Published: 2022
Journal Articles

Effect of Rap-536 on MDS PDX-Murine Models with or without SF3B1 Mutation

Mathieu Meunier, Camille Knosp, Chloe Friedrich, Johanna Zannoni, Jean-Yves Cahn, MD PhD, Olivier Kosmider, PharmD, PhD, Michaela Fontenay, MD PhD, Sophie Park, MD PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 1705.
https://doi.org/10.1182/blood-2019-128407
Published: 2019
Journal Articles

Tumor Microenvironment and Clonal Monocytes of Chronic Myelomonocytic Leukemia Induce a Procoagulant Climate within the Tumor Niche

Natacha Mauz, Mathieu Meunier, MD, Landry Seyve, Julie Brault, PhD, Jean-Yves Cahn, Fabrice Cognasse, PhD, Benoit Polack, MD PhD, Sophie Park, MD PhD
Journal: Blood
Blood (2017) 130 (Supplement 1): 4239.
https://doi.org/10.1182/blood.V130.Suppl_1.4239.4239
Published: 2017
Journal Articles

Comparison of Mobilized Peripheral Blood Stem Cells Versus Unmanipulated Bone Marrow Haploidentical Transplantation Using Post-Transplant Cyclophosphamide: A Retrospective Study of SFGM-TC in 176 Patients

Nathalie Jacque, Jérôme Lambert, MDPhD, Ibrahim Yakoub-Agha, Reza Tabrizi, MD, Mauricette Michallet, MD PhD, Eric Deconinck, MD PhD, Sylvain Thepot, MD, Mathieu Meunier, MD, Regis Peffault De Latour, MD PhD, Felipe Suarez, MDPhD, Amandine Charbonnier, Pascal Turlure, Patrice Ceballos, MD, Gaelle Guillerm, MD, Gerard Michel, MD, Nathalie Contentin, MD, Tony Marchand, Lionel Mannone, MD, Jean-Hugues Dalle, MD PhD, Jean Valère Malfuson, Bruno Lioure, MD, Marie Thérèse Rubio, MD, Stephanie Nguyen, MD PhD
Journal: Blood
Blood (2017) 130 (Supplement 1): 2039.
https://doi.org/10.1182/blood.V130.Suppl_1.2039.2039
Published: 2017
Journal Articles

Dyserythropoiesis Evaluated By Red Score and Hepcidin/Ferritin Levels Predicts Response to Epoetin Zeta in Lower Risk MDS

Olivier Kosmider, Frederic Maloisel, Bernard Drenou, MD, Nicolas Chapuis, PharmD, PhD, Anne Sophie Alary, Alice Rousseau, Cecile Bouilloux, Sarah Ducamp, PhD, Frederique Verdier, Thibaud Lefebvre, Zoubida Karim, Marie-Christine Jacob, Agathe Debliquis, Agnes Charpentier, Pierre Fenaux, MD PhD, Emmanuel Gyan, MDPhD, Bruno Anglaret, Cecile Leyronnas, Selim Corm, Borhane Slama, MD, Stephane Cheze, Kamel Laribi, Shanti Ame, MD, Christian Rose, MD, Florence Lachenal, Andrea Toma, MD PhD, Gian Matteo Pica, MD, Martin Carre, Frederic Garban, Brigitte Pegourie, MD, Jean-Yves Cahn, Mathieu Meunier, MD, Orianne Wagner Ballon, Olivier Herault, MDPhD, Francois Dreyfus, Valerie Bardet, Michaela Fontenay, MD PhD, Sophie Park, MD PhD
Journal: Blood
Blood (2017) 130 (Supplement 1): 1705.
https://doi.org/10.1182/blood.V130.Suppl_1.1705.1705
Published: 2017
Journal Articles

Mechanisms of Improvement of Erythropoiesis with Low Dose Deferasirox in Low Risk Myelodysplastic Syndromes

Mathieu Meunier, Sarah Ancelet, Christine Lefebvre, MD PhD, Josiane Arnaud, Catherine Garrel, Yan Wang, Patrice Faure, Benoit Polack, MD PhD, Jean-Yves Cahn, MD, Sophie Park, MD PhD
Journal: Blood
Blood (2016) 128 (22): 3152.
https://doi.org/10.1182/blood.V128.22.3152.3152
Published: 2016